Claybrook Capital’s Humana HUM Stock Holding History

Claybrook Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3	Closed	-$1K	–	345
2018 Q4	$1K	Buy	+3	New	+$951	﹤0.01%	705

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Claybrook Capital's HUM Position: Q1 2019 in Review

Claybrook Capital sold out of Humana (HUM) in Q1 2019, closing a stake of 3 shares — an estimated $1K sold.

Claybrook Capital first reported a position in HUM in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 741 funds tracked by Wall St. Rank hold HUM as of Q1 2019.

Claybrook Capital reported no remaining Humana position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 3 Humana shares in Q1 2019, an estimated $1K.
Claybrook Capital first reported a position in Humana in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Humana position peaked at $1K in Q4 2018.
741 funds tracked by Wall St. Rank held Humana as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.